ANDA 77438, held by Sandoz. Levofloxacin.
As of Nov 16, 2026, ANDA 77438 (Levofloxacin), held by Sandoz, was first approved by FDA on Jun 20, 2011, with 15 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 20, 2011 | Original application | Approved | None posted |
| Levofloxacin250MG · tablet;oral | Levofloxacin | Discontinued |
| Levofloxacin500MG · tablet;oral | Levofloxacin | Discontinued |
| Levofloxacin750MG · tablet;oral | Levofloxacin | Discontinued |
| Sep 20, 2024 | Supplement 22Labeling · Standard review | Approved | None posted |
| Jun 28, 2023 | Supplement 21Labeling · Standard review | Approved | None posted |
| Apr 6, 2020 | Supplement 19Labeling · Standard review | Approved | None posted |
| May 3, 2019 | Supplement 17Labeling · Standard review | Approved | None posted |
| Apr 26, 2019 | Supplement 16Labeling · Standard review | Approved | None posted |
| Apr 26, 2019 | Supplement 15Labeling · Standard review | Approved | None posted |
| Apr 26, 2019 | Supplement 12Labeling · Standard review | Approved | None posted |
| Apr 26, 2019 | Supplement 11Labeling · Standard review | Approved | None posted |
| Sep 24, 2014 | Supplement 10Labeling · Standard review | Approved | None posted |
| Sep 24, 2014 | Supplement 9Labeling · Standard review | Approved | None posted |
| Mar 4, 2014 | Supplement 2Manufacturing | Approved | None posted |
| Mar 4, 2014 | Supplement 1Manufacturing | Approved | None posted |
| Oct 22, 2012 | Supplement 6Labeling · Standard review | Approved | None posted |
| Feb 10, 2012 | Supplement 4Labeling | Approved | None posted |
| Jan 3, 2012 | Supplement 3Labeling | Approved | None posted |
| Jun 20, 2011 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters